» Articles » PMID: 38238184

Challenges and Knowledge Gaps in the Management of Non-tuberculous Mycobacterial Pulmonary Disease in Sub-Saharan African Countries with a High Tuberculosis Burden: a Scoping Review

Overview
Journal BMJ Open
Specialty General Medicine
Date 2024 Jan 18
PMID 38238184
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: In sub-Saharan African (SSA) countries endemic for tuberculosis (TB), previous TB is a significant risk factor for non-tuberculous mycobacterial pulmonary disease (NTM-PD). The deployment of GeneXpert MTB/RIF in pulmonary TB diagnostic work-up regularly identifies symptomatic patients with a positive smear microscopy but negative GeneXpert, indicative of NTM presence. This scoping review outlines recent evidence for NTM-PD diagnosis and management in SSA.

Objective: The review's objective was to outline the risk factors, available diagnostics, management options and outcomes of NTM-PD in high-burden TB settings in SSA using the population-concept-context framework.

Design And Data Sources: We searched existing literature from PubMed, Web of Science, African Journals Online, Google Scholar and grey literature. Studies published between January 2005 and December 2022 were retained. Data were extracted into Rayyan software and Mendeley and summarised using Excel.

Results: We identified 785 potential articles, of which 105 were included in the full-text review, with 7 papers retained. Included articles used international criteria for diagnosing NTM-PD. Multiple papers were excluded due to non-application of the criteria, suggesting challenging application in the SSA setting. Identified risk factors include previous TB, smoking and mining. Most commonly, chest radiography and not CT was used for the radiological diagnosis of PD, which may miss early changes related to NTM-PD. Molecular methods for NTM species identification were employed in research settings, usually at referral centres, but were unavailable for routine care. Most studies did not report a standardised approach to treatment and they were not offered treatment for the specific disease, marking a lack of guidance in treatment decision-making. When treatment was provided, the outcome was often not reported due to the lack of implementation of standardised outcome definitions.

Conclusions: These outlined challenges present a unique opportunity for researchers to undertake further studies in NTM-PD and proffer solutions more applicable to SSA.

Citing Articles

A novel hematological score (HS) and its related nomogram model to predict nontuberculous mycobacterial pulmonary disease in patients with suspected multidrug-resistant pulmonary tuberculosis.

Yu Q, Hu S, Liu F, Gong F Ann Med. 2024; 56(1):2409965.

PMID: 39348285 PMC: 11443538. DOI: 10.1080/07853890.2024.2409965.


Prevalence and predictors of NTM in presumed/confirmed drug-resistant TB.

Abbew E, Laryea R, Sorvor F, Poku Y, Lorent N, Obiri-Yeboah D IJTLD Open. 2024; 1(7):306-313.

PMID: 39035428 PMC: 11257093. DOI: 10.5588/ijtldopen.24.0242.

References
1.
Dahl V, Molhave M, Floe A, van Ingen J, Schon T, Lillebaek T . Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review. Int J Infect Dis. 2022; 125:120-131. DOI: 10.1016/j.ijid.2022.10.013. View

2.
Okoi C, Anderson S, Antonio M, Mulwa S, Gehre F, Adetifa I . Non-tuberculous Mycobacteria isolated from Pulmonary samples in sub-Saharan Africa - A Systematic Review and Meta Analyses. Sci Rep. 2017; 7(1):12002. PMC: 5607231. DOI: 10.1038/s41598-017-12175-z. View

3.
Nishtar T, Burki S, Ahmad F, Ahmad T . Diagnostic accuracy of computer aided reading of chest x-ray in screening for pulmonary tuberculosis in comparison with Gene-Xpert. Pak J Med Sci. 2022; 38(1):62-68. PMC: 8713241. DOI: 10.12669/pjms.38.1.4531. View

4.
Ramsay L, Shing E, Wang J, Marras T, Kwong J, Brode S . Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001-2012. Emerg Infect Dis. 2020; 26(9):2097-2107. PMC: 7454113. DOI: 10.3201/eid2609.190524. View

5.
Agizew T, Basotli J, Alexander H, Boyd R, Letsibogo G, Auld A . Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay. PLoS One. 2017; 12(12):e0189981. PMC: 5741233. DOI: 10.1371/journal.pone.0189981. View